Across rheumatic diseases

Impact of Risk Factors on COVID‐19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID‐19 Global Rheumatology Alliance Registry

Arthritis Care Res (Hoboken)Published Registry-based cohort study

Authors' conclusion

Risk factors for severe COVID-19 outcomes were similar throughout pandemic epochs in unvaccinated people with RDs.

Study context

Population
Unvaccinated patients with rheumatic diseases and COVID-19 in the COVID-19 Global Rheumatology Alliance Registry, March 2020–June 2022
Participants
19,256 patients
Exposure
Risk factors for severe COVID-19 across pandemic epochs
Outcome
Severe COVID-19 (main analysis: risk factors across pandemic epochs in all unvaccinated patients; ordinal outcome: not hospitalized, hospitalized, death)
Methodological detailsordinal logistic regression (not hospitalized, hospitalized, death), stratified by pandemic epoch, subanalyses by RD type
  • Ordinal logistic regression (not hospitalized, hospitalized, death)
  • Stratified by pandemic epoch
  • Subanalyses by RD type

Main finding

As reported in the abstract

Risk factors for worse COVID-19 outcomes across epochs
  • Older age, male sex, more comorbidities, GC use, higher disease activity and lower human development index (HDI) regions associated with worse outcomes across epochs

Observational data: associations, not effects.

Further findings

RA subgroup

SSZ and B-cell-depleting therapy associated with worse outcomes
TNFi associated with improved outcomes

Connective tissue disease or vasculitis subgroup

B-cell-depleting therapy associated with worse outcomes

Original publication

Impact of Risk Factors on COVID‐19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID‐19 Global Rheumatology Alliance Registry. Arthritis Care Res (Hoboken). Published 7 November 2023. doi:10.1002/acr.25220

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.